Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 65

1.

Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials.

Lee AW, Tung SY, Ngan RK, Chappell R, Chua DT, Lu TX, Siu L, Tan T, Chan LK, Ng WT, Leung TW, Fu YT, Au GK, Zhao C, O'Sullivan B, Tan EH, Lau WH.

Eur J Cancer. 2011 Mar;47(5):656-66. doi: 10.1016/j.ejca.2010.10.026. Epub 2010 Nov 26.

PMID:
21112774
2.

A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma.

Lee AW, Tung SY, Chan AT, Chappell R, Fu YT, Lu TX, Tan T, Chua DT, O'Sullivan B, Tung R, Ng WT, Leung TW, Leung SF, Yau S, Zhao C, Tan EH, Au GK, Siu L, Fung KK, Lau WH.

Radiother Oncol. 2011 Jan;98(1):15-22. doi: 10.1016/j.radonc.2010.09.023.

PMID:
20971520
3.

Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.

Lee AW, Tung SY, Chua DT, Ngan RK, Chappell R, Tung R, Siu L, Ng WT, Sze WK, Au GK, Law SC, O'Sullivan B, Yau TK, Leung TW, Au JS, Sze WM, Choi CW, Fung KK, Lau JT, Lau WH.

J Natl Cancer Inst. 2010 Aug 4;102(15):1188-98. doi: 10.1093/jnci/djq258. Epub 2010 Jul 15.

PMID:
20634482
4.

Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome.

Lee CC, Huang TT, Lee MS, Hsiao SH, Lin HY, Su YC, Hsu FC, Hung SK.

Radiat Oncol. 2010 Mar 11;5:20. doi: 10.1186/1748-717X-5-20.

5.

Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.

Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, Jones C, Ang KK.

J Clin Oncol. 2009 Aug 1;27(22):3684-90. doi: 10.1200/JCO.2008.19.9109. Epub 2009 Jun 29.

6.

Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy.

Koutcher L, Lee N, Zelefsky M, Chan K, Cohen G, Pfister D, Kraus D, Wolden S.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):130-7. doi: 10.1016/j.ijrobp.2009.01.055.

PMID:
19467802
7.

Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone.

Chen CY, Han F, Zhao C, Lu LX, Sun Y, Liu XF, Lu TX.

Br J Radiol. 2009 Jun;82(978):452-8. doi: 10.1259/bjr/72813246.

PMID:
19451314
8.

Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma.

Xiao WW, Han F, Lu TX, Chen CY, Huang Y, Zhao C.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1070-6. doi: 10.1016/j.ijrobp.2008.09.008. Epub 2009 Feb 21.

PMID:
19231110
9.

Alcohol consumption and the risk of nasopharyngeal carcinoma: a systematic review.

Chen L, Gallicchio L, Boyd-Lindsley K, Tao XG, Robinson KA, Lam TK, Herman JG, Caulfield LE, Guallar E, Alberg AJ.

Nutr Cancer. 2009;61(1):1-15. doi: 10.1080/01635580802372633. Review.

10.

Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.

Hui EP, Ma BB, Leung SF, King AD, Mo F, Kam MK, Yu BK, Chiu SK, Kwan WH, Ho R, Chan I, Ahuja AT, Zee BC, Chan AT.

J Clin Oncol. 2009 Jan 10;27(2):242-9. doi: 10.1200/JCO.2008.18.1545. Epub 2008 Dec 8.

PMID:
19064973
11.

Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.

Chen Y, Liu MZ, Liang SB, Zong JF, Mao YP, Tang LL, Guo Y, Lin AH, Zeng XF, Ma J.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1356-64. doi: 10.1016/j.ijrobp.2007.12.028. Epub 2008 May 9.

PMID:
18472356
12.

Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, Lai M, Ho R, Cheung KY, Yu BK, Chiu SK, Choi PH, Teo PM, Kwan WH, Chan AT.

J Clin Oncol. 2007 Nov 1;25(31):4873-9.

PMID:
17971582
13.

Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial.

Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P, Sumitsawan Y, Tharavichitkul E, Sukthomya V, Ford J.

Eur J Cancer. 2007 Jun;43(9):1399-406. Epub 2007 Apr 27.

PMID:
17467265
14.
15.

Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma.

Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, Kwong DL, Al-Sarraf M, Chi KH, Hareyama M, Leung SF, Thephamongkhol K, Pignon JP; MAC-NPC Collaborative Group.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004329. Review.

PMID:
17054200
16.

[18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging.

Liu FY, Chang JT, Wang HM, Liao CT, Kang CJ, Ng SH, Chan SC, Yen TC.

J Clin Oncol. 2006 Feb 1;24(4):599-604. Erratum in: J Clin Oncol. 2006 Jul 20;24(21):3515. Ng, Shu-Kung [corrected to Ng, Shu-Hang].

PMID:
16446332
17.

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, Kwong DL, Al-Sarraf M, Chi KH, Hareyama M, Leung SF, Thephamongkhol K, Pignon JP; MAC-NPC Collaborative Group.

Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):47-56. Review.

PMID:
16377415
18.

Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results.

Zhang L, Zhao C, Peng PJ, Lu LX, Huang PY, Han F, Wu SX.

J Clin Oncol. 2005 Nov 20;23(33):8461-8. Epub 2005 Oct 17.

PMID:
16230677
19.

Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.

Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L, Siu L, Sze WM, Leung TW, Sham JS, Ngan RK, Law SC, Yau TK, Au JS, O'Sullivan B, Pang ES, O SK, Au GK, Lau JT; Hong Kong Nasopharyngeal Cancer Study Group.

J Clin Oncol. 2005 Oct 1;23(28):6966-75.

PMID:
16192584
20.

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.

Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW, Tan HS, Lee KS, Loong S, Sethi V, Chua EJ, Machin D.

J Clin Oncol. 2005 Sep 20;23(27):6730-8.

PMID:
16170180

Supplemental Content

Support Center